Ablation of the CD9 receptor in human lung cancer cells using CRISPR/Cas alters migration to chemoattractants including IL‐16

@article{Blake2018AblationOT,
  title={Ablation of the CD9 receptor in human lung cancer cells using CRISPR/Cas alters migration to chemoattractants including IL‐16},
  author={D. Blake and Jonathon D Martiszus and Tia H Lone and Steven D Fenster},
  journal={Cytokine},
  year={2018},
  volume={111},
  pages={567–570}
}
  • D. Blake, Jonathon D Martiszus, +1 author Steven D Fenster
  • Published 2018
  • Chemistry, Medicine
  • Cytokine
  • Graphical abstract Figure. No caption available. HighlightsCD9 expression was ablated in A549 cells using CRISPR/Cas technology.Wild‐type A549 cells migrated towards chemoattractants, however, CD9 expression was required in this process.CD9 knockdown cells had a significantly reduced migration towards growth serum and IL‐16.IL‐16 stimulation does not lead to the activation of a stress response in A549 cells. Abstract CD9, a member of the tetraspanin superfamily, has been implicated in… CONTINUE READING
    4 Citations

    References

    SHOWING 1-10 OF 15 REFERENCES
    IL-16 effects on A549 lung epithelial cells: Dependence on CD9 as an IL-16 receptor?
    • 9
    Regulation of Cellular Processes by Interleukin‐16 in Homeostasis and Cancer
    • 66
    Cutting Edge: CD4 Is Not Required for the Functional Activity of IL-161
    • 79
    • PDF
    Human and mouse mast cells use the tetraspanin CD9 as an alternate interleukin-16 receptor.
    • 67
    IL-16 activates the SAPK signaling pathway in CD4+ macrophages.
    • 45
    HIV‐1 infection is facilitated in T cells by decreasing p56lck protein tyrosine kinase activity
    • 25
    Soluble extracellular Klotho decreases sensitivity to cigarette smoke induced cell death in human lung epithelial cells.
    • 12
    • PDF
    CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration
    • 211
    • PDF